Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review
- PMID: 17971194
- PMCID: PMC2174495
- DOI: 10.1186/1752-1947-1-121
Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review
Abstract
Graft-versus-host disease is one of the most frequent complications occurring after haematopoietic stem cell transplantation. Recently, renal involvement has been described as a manifestation of chronic graft-versus-host disease. Immunosuppression seems to play a major role: clinical disease is triggered by its tapering and resolution is achieved with the resumption of the immunosuppressive therapy. Prognosis is apparently favourable, but long term follow up data are lacking.We report a case of a 53-year-old man who developed nephrotic syndrome 142 days after allogeneic stem cell transplantation for acute myeloid leukaemia. Onset of nephrotic syndrome occurred after reduction of immunosuppressants and was accompanied by manifestations of chronic graft-versus-host disease. Histological examination of the kidney was consistent with Minimal Change Disease. After treatment with prednisolone and mycophenolate mofetil he had complete remission of proteinuria and improvement of graft-versus-host disease. Eighteen months after transplantation the patient keeps haematological remission and normal renal function, without proteinuria.Since patients with chronic graft-versus-host disease might be considered at risk for development of nephrotic syndrome, careful monitoring of renal parameters, namely proteinuria, is advisable.
Figures




Similar articles
-
Chronic graft-versus-host disease complicated by nephrotic syndrome.J Chin Med Assoc. 2011 Sep;74(9):419-22. doi: 10.1016/j.jcma.2011.08.008. Epub 2011 Sep 23. J Chin Med Assoc. 2011. PMID: 21962251
-
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.Transplantation. 2006 Apr 27;81(8):1087-92. doi: 10.1097/01.tp.0000209496.26639.cb. Transplantation. 2006. PMID: 16641591
-
[Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation].Nihon Jinzo Gakkai Shi. 2013;55(7):1327-34. Nihon Jinzo Gakkai Shi. 2013. PMID: 24288970 Japanese.
-
[Transient nephrotic syndrome after allogeneic bone marrow transplantation for chronic myelogenous leukemia].Rinsho Ketsueki. 2001 Apr;42(4):321-7. Rinsho Ketsueki. 2001. PMID: 11400304 Review. Japanese.
-
[Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].Vnitr Lek. 2009 Nov;55(11):1089-96. Vnitr Lek. 2009. PMID: 20017442 Review. Czech.
Cited by
-
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms.Clin Kidney J. 2023 Feb 6;16(6):896-900. doi: 10.1093/ckj/sfad023. eCollection 2023 Jun. Clin Kidney J. 2023. PMID: 37261003 Free PMC article.
-
Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus-Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation.Kidney Int Rep. 2020 Oct 17;6(1):224-227. doi: 10.1016/j.ekir.2020.10.012. eCollection 2021 Jan. Kidney Int Rep. 2020. PMID: 33426402 Free PMC article. No abstract available.
-
Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival.Biol Blood Marrow Transplant. 2008 Dec;14(12):1365-72. doi: 10.1016/j.bbmt.2008.09.015. Biol Blood Marrow Transplant. 2008. PMID: 19041058 Free PMC article.
-
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.Transplant Cell Ther. 2022 Aug;28(8):426-445. doi: 10.1016/j.jtct.2022.05.038. Epub 2022 May 31. Transplant Cell Ther. 2022. PMID: 35662591 Free PMC article. Review.
References
-
- Imai H, Ohyama Y, Miura AB, Endoh M, Sakai H. Haematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis. 2000;36:474–480. - PubMed
-
- Kemper MJ, Güngör T, Halter J, Schanz U, Neuhaus TJ. Favorable long-term outcome of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation. Clinical Nephrology. 2007;67:5–11. - PubMed
-
- Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Chronic graft-versus-host disease : clinical manifestation and therapy. Haematopoietic Cell Transplant. 2001;28:121–129. - PubMed
-
- Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Blood and Marrow Transplant. 2005;11:945–955. doi: 10.1016/j.bbmt.2005.09.004. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources